FarleyEYangMD

Physician

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10460 N 92nd St
Ste 101
Scottsdale, AZ 85258
Phone+1 480-922-4600

Fax+1 480-922-5231

University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1993 - 1997
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1992 - 1993
University of Michigan Medical SchoolClass of 1992

PubMed

13 citations
Analysis of Saliva Gene Expression during Head and Neck Cancer Radiotherapy: A Pilot Study
Jerome Lacombe, Carla Brooks, Chengcheng Hu, Emmanuel Menashi, Ronald Korn
Radiation Research. 2017-05-15
5 citations
A new look at an old option in the treatment of early-stage prostate cancer: Hormone therapy as an alternative to watchful waiting
Farley E. Yang, Paul Y. Song, J. Wayne, F. Vaida, Srinivasan Vijayakumar
Medical Hypotheses. 1998-09-01
43 citations
The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for Stage C prostate cancer
Farley E. Yang, George T.Y. Chen, Paul Ray, Florin Vaida, Parvathi Chiru
International Journal of Radiation Oncology, Biology, Physics. 1995-12-01

Journal Articles

Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens
G B Beck-Engeser 1 , P A Monach, D Mumberg, F Yang, S Wanderling, K Schreiber, R Espinosa 3rd, M M Le Beau, S C Meredith, H Schreiber, J Exp Med, 8/6/2001

Point mutation in essential genes with loss or mutation of the second alleleAugust 2001